Regulatory mechanisms of circulating fibroblast growth factor 23 in parathyroid diseases (Q36988383)

17 August 2017

1 reference

title

Regulatory mechanisms of circulating fibroblast growth factor 23 in parathyroid diseases (English)

1 reference

17 August 2017

Yasuo Imanishi

1

1 reference

17 August 2017

Keisuke Kobayashi

2

1 reference

17 August 2017

Takehisa Kawata

3

1 reference

17 August 2017

Masaaki Inaba

4

1 reference

17 August 2017

Yoshiki Nishizawa

5

1 reference

17 August 2017

1 October 2007

1 reference

Therapeutic Apheresis and Dialysis

17 August 2017

1 reference

17 August 2017

11 Suppl 1

1 reference

17 August 2017

S32-7

1 reference

Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia

17 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2007.00519.X

Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2007.00519.X

Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2007.00519.X

Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2007.00519.X

Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2007.00519.X

Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2007.00519.X

Expression of FGF23 is correlated with serum phosphate level in isolated fibrous dysplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2007.00519.X

Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25-dihydroxyvitamin D metabolism in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2007.00519.X

Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2007.00519.X

Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2007.00519.X

Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2007.00519.X

Hyperostosis-hyperphosphatemia syndrome: a congenital disorder of O-glycosylation associated with augmented processing of fibroblast growth factor 23.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2007.00519.X

An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2007.00519.X

A novel mutation in fibroblast growth factor 23 gene as a cause of tumoral calcinosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2007.00519.X

FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2007.00519.X

FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2007.00519.X

FGF-23 is elevated by chronic hyperphosphatemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2007.00519.X

Circulating FGF-23 is regulated by 1alpha,25-dihydroxyvitamin D3 and phosphorus in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2007.00519.X

Fibroblast growth factor-23 is regulated by 1alpha,25-dihydroxyvitamin D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2007.00519.X

Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2007.00519.X

Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2007.00519.X

Clonal Chromosomal Defects in the Molecular Pathogenesis of Refractory Hyperparathyroidism of Uremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2007.00519.X

Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2007.00519.X

Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2007.00519.X

Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2007.00519.X

FGF-23 in patients with end-stage renal disease on hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2007.00519.X

Sevelamer hydrochloride and calcium bicarbonate reduce serum fibroblast growth factor 23 levels in dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2007.00519.X

Fibroblast growth factor (FGF)-23 in patients with primary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2007.00519.X

Regulation of plasma fibroblast growth factor 23 by calcium in primary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2007.00519.X

Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2007.00519.X

Genetic ablation of vitamin D activation pathway reverses biochemical and skeletal anomalies in Fgf-23-null animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2007.00519.X

Ablation of vitamin D signaling rescues bone, mineral, and glucose homeostasis in Fgf-23 deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2007.00519.X

10.1111/J.1744-9987.2007.00519.X

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference